Login / Signup
Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
Kenneth I Ataga
Steven J Staffa
Carlo Brugnara
Jonathan W Stocker
Published in:
British journal of haematology (2021)
Keyphrases
</>
phase iii
clinical trial
open label
end stage renal disease
phase ii
newly diagnosed
ejection fraction
chronic kidney disease
double blind
study protocol
placebo controlled
randomized controlled trial
patient reported outcomes